My research area focuses on the genetics and pharmacogenetics of psychiatric disorders. Almost all psychiatric disorders are complex and heterogeneous in nature and my research aims to identify homogeneous phenotypes, specifically cognitive profiles, in psychiatric disorders, and to examine the genetics of these specific phenotypes. The main disorders that I am interested in include schizophrenia and obsessive-compulsive and related disorders. Through genetics and pharmacogenetics research, my clinical goals are to choose the best therapy for each patient using personalized medicine in order to avoid adverse drug reaction and to maximize drug efficacy. My scientific goals are to link genetic variations to variations in phenotypes, in order to determine mechanisms responsible for that link, and to translate the identified link into enhanced understanding, treatment, and prevention of psychiatry disorders.